Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dopamine Antagonists in Pathological Gambling
NCT02203786Phase 2Completed
- Sponsor
- Center for Addiction and Mental Health
- Start
- Sep 2009
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of haloperidol, fluphenazine in gambling disorder (GD), sponsored by Center for Addiction and Mental Health. Started Sep 2009; status: completed.
02
Drugs
haloperidolfluphenazine
03
Conditions
gambling disorder (GD)
Beyond the preview
Go deeper on NCT02203786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02203786.